Joseph Patrick Cooper - 26 Oct 2023 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Director
Signature
/s/ Joseph Cooper
Issuer symbol
QNRX
Transactions as of
26 Oct 2023
Net transactions value
$0
Form type
4
Filing time
30 Oct 2023, 16:08:53 UTC
Previous filing
07 Mar 2023
Next filing
10 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNRX Share Option (Right to Buy) Award $0 +7,652 $0.000000 7,652 26 Oct 2023 American Depositary Share 7,652 $5.75 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS.
F2 The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027.